Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by icecubeon Sep 29, 2015 3:31pm

46 Views

Post# 24146358

RE:RE:Caution

It is interesting how the person who was pumping the stock the hardest up at $19 is now trashing it the most.

truthseeker2012 wrote: Volkswagon had fraud & their stock is down 35%. CPH is now down 70% since Innocutis deal announced & everything is good?

Tell me how much does CPH have to overpay for a deal & how much they have to over pay exec salaries for it not to be fraud? Mr lawyer!

We even had insider selling by the CFO shortly before the August plunge! The smoking gun. Didn't Martha Stewart get nailed for something like that?